Maria Chaparro-Montiel
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Psychomotor Development in Infants Following Maternal Exposure to Biologics: Results From the DUMBO Registry.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: March 31, 2025
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU.
Journal: Gut
Published: August 02, 2024
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis.
Journal: Clinical drug investigation
Published: February 28, 2024
New drugs for the treatment of IBD during conception, pregnancy, and lactation.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: May 08, 2023
Immunomodulatory Effect of Gut Microbiota-Derived Bioactive Peptides on Human Immune System from Healthy Controls and Patients with Inflammatory Bowel Disease.
Journal: Nutrients
Published: September 20, 2019
Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.
Journal: Digestive diseases and sciences
Published: August 10, 2018
Treatment of inflammatory bowel disease: what's new in Digestive Disease Week 2016.
Journal: Gastroenterologia y hepatologia
Published: November 28, 2016
Natural history, complications, safety and pregnancy in inflammatory bowel disease
Journal: Gastroenterologia y hepatologia
Published: November 02, 2015
Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease - authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: September 03, 2015
New molecules in the treatment of inflammatory bowel disease
Journal: Gastroenterologia y hepatologia
Published: July 17, 2015
Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.
Journal: Digestive diseases and sciences
Published: March 10, 2015
Outcome after a dose "de-intensification" strategy with anti-TNF drugs in patients with Crohn's disease.
Journal: Gastroenterologia y hepatologia
Published: November 21, 2014
Last Updated: 09/26/2026